Industry: Healthcare
Published Date: March-2025
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 183
Report ID: PMRREP35173
The global fertility tourism market size is anticipated to reach a value of US$ 2,046.4 Mn in 2025 and is set to witness a CAGR of 30.3% from 2025 to 2032. The market will likely attain a value of US$ 13,080.0 Mn in 2032.
Fertility tourism has become a significant industry. There has been a surge in the number of ‘fertility tourists’ from wealthy countries traveling to low-income countries and crossing national boundaries to achieve childbirth and conception.
Various facilities in Southern European regions and countries like Cyprus and Spain are providing ‘IVF holidays’ to wealthy patients looking for reproductive services. Thailand and Singapore are also considered key destinations for fertility tourism.
Key Highlights of the Fertility Tourism Industry
|
Global Market Attributes |
Key Insights |
|
Fertility Tourism Market Size (2025E) |
US$ 2,046.4 Mn |
|
Market Value Forecast (2032F) |
US$ 13,080.0 Mn |
|
Projected Growth (CAGR 2025 to 2032) |
30.3% |
|
Historical Market Growth (CAGR 2019 to 2024) |
23.8% |
Spain, Greece, and India Attracted Several Patients in Historical Period due to Low Treatment Costs
As per Persistence Market Research, in the historical period from 2019 to 2024, the global fertility tourism industry witnessed a considerable CAGR of around 23.8%. Fertility tourism peaked in 2019 and early 2020, when thousands of patients traveled from all over the world for procedures like surrogacy, egg donation, and in vitro fertilization (IVF). Spain, Greece, and India were the most popular locations because of their low costs, favorable norms, high success rates, and donor programs that were well-regulated.
As per the European Society of Human Reproduction and Embryology (ESHRE), for example, with about 12,000 international patients a year, Spain accounted for more than 40% of cross-border fertility treatments in Europe. In Greece, on the other hand, international patients struggling with fertility had the same rights as local people due to the government’s well-defined legal frameworks.
Between mid-2020 and 2021, the COVID-19 pandemic significantly hindered the market. The Journal of Assisted Reproduction and Genetics, for instance, revealed that overburdened healthcare systems, travel restrictions, and lockdowns resulted in a 60 to 70% decline in international fertility treatments.
The market for reproductive tourism rebounded to a certain extent by the end of 2021. The International Fertility Medical Group mentioned that compared to pre-pandemic levels, countries like Czech Republic and Greece witnessed a surge of 30% to 40% in international fertility patients.
Between 2023 and 2024, the market saw developments in embryo freezing and preimplantation genetic testing (PGT) across various countries. These helped enhance success rates, making countries like Mexico, Cyprus, and Spain highly attractive destinations.
NHS Fertility Treatment Cuts in the U.K. to Propel Patients toward Fertility Tourism through 2032
From 2025 to 2032, the fertility tourism industry is likely to showcase an impressive CAGR of 30.3%. The forecast period is estimated to see more patients from the U.K. travel to other countries to achieve better treatment. Even though the country has been the birthplace of IVF, cuts to National Health Service (NHS) fertility treatments are projected to lead to some individuals crossing the borders.
For those who meet the criteria, the National Institute for Health and Care Excellence suggests 3 cycles of IVF. However, the patient’s locality will determine whether they receive the treatment. Fertility Clinics Abroad and Fertility Network UK conducted surveys and found that high costs of private IVF and patchy NHS provision are the main reasons why patients in the U.K. are looking to travel abroad.
The market is anticipated to witness high demand among patients for accessible and affordable treatment options abroad. Countries with high success rates, reduced costs, and clear treatment policies are likely to attract patients from all over the world through 2032.
Increasing Domestic Treatment Costs to Push Patients to Seek Fertility Treatment Abroad
Fertility tourism has been gaining popularity in recent years as couples and individuals facing infertility are looking for superior yet low-cost treatment options abroad. They are aiming to travel to those countries where procedures like surrogacy, egg and sperm donation, IVF, and intrauterine insemination (IUI) are more accessible and cost-effective than their home countries.
Such significant cost variations are set to make the aforementioned countries top fertility tourism destinations. These countries are further projected to offer customized travel packages to make the entire process as smooth as possible for patients. Leading destinations are now providing international patients with all-inclusive packages to cover legal support, accommodation, and treatment, thereby attracting more individuals.
Restrictive Policies on Assisted Reproduction in Countries like Italy May Limit Cross-border Treatment Access
A handful of countries are tightening legal restrictions on reproductive treatments if looked for abroad. Even though several countries have adopted assisted reproductive treatments, others are likely to implement stringent norms to prevent locals from seeking cross-border treatment. Political influences, ethical issues, and legal barriers are anticipated to hinder the field of fertility tourism. These are further likely to create issues for intended parents to gain access to affordable treatment in international facilities.
Citizens of Italy, for instance, are no longer allowed to travel overseas to have a baby through surrogacy. The law, passed in October 2024, extended a ban on the practice in the country to also include those who search for it in Canada or the U.S., where surrogacy is legal. Individuals breaking this law will have to pay fines of up to €1 Mn and face nearly 2 years in prison. The law was put forward by the country’s far-right governing party and it passed by 84 votes to 58.
Colombia's Flourishing Medical Tourism Industry to Boost Growth of Fertility Treatments
Columbia, a country whose tourism and medical scene is flourishing, is anticipated to create new opportunities in the foreseeable future. The country is likely to emerge as a reliable and comprehensive destination for those looking for assisted reproduction treatments.
Fertility clinics in Columbia are required to follow international guidelines to ensure globally accepted standards of care. These clinics provide effective and personalized fertility solutions. Patients are recommended to opt for clinics and hospitals accredited by Global Healthcare or those who have achieved certification from the Certified Medical Travel Professionals (CMTP). Such initiatives are anticipated to help ensure high quality care.
Even though Spanish is the primary language of Columbia, English proficiency is relatively high in the country’s healthcare sector. Various clinics are now providing translation services to facilitate successful communication.
Innovations in Reproductive Medicine to Extend IVF Options for Women Over 40
In the global fertility tourism industry, the in vitro fertilization (IVF) segment is projected to hold a share of 47.6% in 2025. The rising success rates linked to using one's own eggs in fertility treatments are a key factor propelling demand for IVF. Several individuals and couples are choosing this treatment type as research indicates that using a woman's own eggs greatly increases the likelihood of a successful pregnancy, particularly for women over 35.
A May 2024 update from Babies & Us Fertility IVF & ICSI Center states that women between the age group of 42 and 49 years can, in fact, use their own eggs for IVF treatment. Women over 40 years can now opt for this option due to developments in reproductive medicine. Additionally, IVF treatment uses a more customized approach as it provides women the opportunity to choose embryos based on their genetic makeup.
Egg and sperm donation, on the other hand, is anticipated to exhibit a decent CAGR through 2032. This treatment type is considered an ideal option for women with low ovarian reserve or those above 40 years, with a desire to have biological children. The Society for Assisted Reproductive Technology (SART), for example, revealed that in the U.S., the success rate of IVF with donor eggs is around 55 to 60% per cycle, compared to 30 to 35% with a women’s own eggs once she crosses 40.
Young adults diagnosed with cancer often decide to freeze their eggs or sperm. However, if they previously failed to preserve their gametes, donation is considered an option for becoming parents. The American Cancer Society estimates that every year, in the U.S., nearly 8,000 cancer patients who are unable to conceive because of their treatment, resort to using donor eggs or sperm.
Declining Natural Fertility After 30 to Raise Demand for Treatment across International IVF Clinics
By age group, the 30 to 39 years segment will likely generate a fertility tourism market share of 41.9% in 2025. One of the main reasons for growth is the high rate of infertility among this age group.
The group's reproductive decisions are frequently influenced by a confluence of socioeconomic and biological factors. Due to biological factors, women in this age group tend to be more conscious of their declining ability to conceive, which may encourage them to seek assisted reproductive technology as soon as possible.
In April 2023, the Centers for Disease Control and Prevention (CDC), for example, found that as women age, their fertility rate gradually decreases. With a 54% to 56% likelihood of becoming pregnant, women over 35 years of age are more likely to seek treatment for infertility issues. This age group is also more likely to be aware of international healthcare facilities through social media and digital platforms, which increases their propensity to look into innovative clinics that specialize in reproductive treatments.
The 40 to 49 years segment, on the other hand, is anticipated to showcase a considerable CAGR through 2032. Due to declining egg quality and ovarian reserve, women falling under this age group often face low pregnancy success rates.
The American Society for Reproductive Medicine (ASRM), for instance, states that women over 40 have a natural conception rate of 5% every cycle, which falls to fewer than 1% by the age of 45. Hence, several women under this age group are set to shift to fertility tourism to gain cost-effective reproductive treatments and egg donation services with high success rates.
U.S. Allows for Parental Rights via Pre-birth Orders, Bolstering Fertility Tourism
North America is anticipated to hold a share of around 26.9% in 2025. In the region, the U.S. has become a notable destination for fertility tourism. More than 30,000 babies are born every year in the U.S. through ART, says the American Society for Reproductive Medicine (ASRM), with a significant share of international patients seeking treatments.
The U.S. fertility tourism market is further set to rise as gestational surrogacy, which is either heavily restricted or banned in various parts of the world, faces no limitations. Leading surrogacy-friendly states in the U.S., such as Connecticut, Illinois, and California allow intended parents to obtain parental rights through pre-birth orders, regardless of their sexual orientation, marital status, or nationality.
India’s ART Regulation Act to Strengthen Ethical and Quality Standards in Fertility Treatments
Asia Pacific is projected to be dominated by India, Thailand, and Malaysia. India has recently emerged as a significant destination for fertility tourism. Clinics in the country are mandated to comply with strict Assisted Reproductive Technology (ART) guidelines.
The Assisted Reproductive Technology (Regulation) Act, 2021, for instance, provides a regulatory framework to maintain standards in ART services, safeguard the rights of patients, and improve ethical practices. The legislation has created a transparent environment in the country, thereby addressing accessibility and quality issues associated with reproductive technologies.
Thailand, on the other hand, has created a reputation for providing superior-quality fertility treatment at an affordable rate. The country houses several internationally accredited hospitals and clinics specializing in fertility treatment, such as Jetanin Institute for Assisted Reproduction and Bangkok Hospital. These often maintain high success rates, making Thailand an ideal choice for treatments.
Malaysia is set to gain traction in the field of fertility tourism as the country’s government is striving to promote it as an international destination through initiatives like Malaysia Healthcare Travel Council (MHTC). The government campaign called Malaysia Year of Healthcare Travel 2024 supported partnerships with top-notch fertility clinics to attract more patients.
Spain’s Compensation and Anonymity Laws to Bolster Demand for Donor Treatments
In Europe, Spain and the Czech Republic are projected to remain at the forefront in the market for fertility tourism. Spain offers financial compensation and has implemented anonymity laws for egg and sperm donors. It has led to thousands of patients traveling to the country, especially for donor treatments, with IVF success rates surpassing around 55% in key clinics like IVI Madrid and Instituto Bernabeu.
The Czech Republic, on the other hand, has become an important fertility tourism destination in recent years. As per the European Society of Human Reproduction and Embryology (ESHRE), more than 30,000 fertility treatments are conducted in the country every year, with international patients accounting for around 50% of all cycles.
The country’s favorable norms allow for fertility preservation, which is specifically ideal for women looking for egg freezing. It has resulted in an influx of patients living with medical conditions like cancer who seek long-term fertility preservation solutions.
The global market for fertility tourism is projected to witness rapid developments in terms of facility expansions. Several government-backed as well as private firms are focusing on constructing new fertility centers across countries like India, Qatar, and the UAE. They are equipping their facilities with cutting-edge medical equipment and devices to offer top-notch treatment.
|
Report Attributes |
Details |
|
Historical Data/Actuals |
2019 - 2024 |
|
Forecast Period |
2025 - 2032 |
|
Market Analysis Units |
Value: US$ Bn/Mn, Volume: As applicable |
|
Geographical Coverage |
|
|
Segmental Coverage |
|
|
Competitive Analysis |
|
|
Report Highlights |
|
|
Customization and Pricing |
Available upon request |
By Treatment Type
By Age Group
By Region
To know more about delivery timeline for this report Contact Sales
The market is set to reach US$ 2,046.4 Mn in 2025.
The industry will likely be valued at US$ 13,080.0 Mn in 2032.
The industry is set to surge at a CAGR of 30.3% through 2032.
San Diego Fertility Center, IVF-Life, Barcelona IVF, and Eva Fertility Clinics are the key players in the industry.
IVF is anticipated to lead the market in 2025.
